Core Laboratories Inc. (NYSE:CLB) Shares Purchased by State Street Corp

State Street Corp boosted its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 2.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,975,016 shares of the oil and gas company's stock after purchasing an additional 56,187 shares during the period. State Street Corp owned about 4.21% of Core Laboratories worth $36,597,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CLB. Disciplined Growth Investors Inc. MN lifted its position in shares of Core Laboratories by 446.8% during the second quarter. Disciplined Growth Investors Inc. MN now owns 4,460,720 shares of the oil and gas company's stock worth $90,508,000 after purchasing an additional 3,644,963 shares during the last quarter. Earnest Partners LLC lifted its holdings in Core Laboratories by 6.3% during the 2nd quarter. Earnest Partners LLC now owns 3,286,438 shares of the oil and gas company's stock valued at $66,682,000 after buying an additional 195,756 shares in the last quarter. Royce & Associates LP boosted its position in Core Laboratories by 9.0% in the 3rd quarter. Royce & Associates LP now owns 1,021,121 shares of the oil and gas company's stock valued at $18,921,000 after buying an additional 84,022 shares during the period. Fisher Asset Management LLC grew its stake in Core Laboratories by 19.5% in the 3rd quarter. Fisher Asset Management LLC now owns 990,267 shares of the oil and gas company's stock worth $18,350,000 after acquiring an additional 161,278 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its position in shares of Core Laboratories by 8.1% during the second quarter. Bank of New York Mellon Corp now owns 516,119 shares of the oil and gas company's stock worth $10,472,000 after acquiring an additional 38,726 shares during the period. 97.81% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

CLB has been the subject of a number of research reports. Citigroup lowered their price target on Core Laboratories from $15.00 to $14.00 and set a "sell" rating for the company in a report on Thursday, October 31st. StockNews.com upgraded Core Laboratories from a "sell" rating to a "hold" rating in a report on Thursday, November 7th. Two research analysts have rated the stock with a sell rating and three have given a hold rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $17.00.

Core Laboratories Stock Down 4.4 %

Shares of CLB traded down $0.78 during mid-day trading on Friday, hitting $16.85. The company's stock had a trading volume of 1,101,233 shares, compared to its average volume of 413,496. The firm has a market capitalization of $791.11 million, a price-to-earnings ratio of 25.92, a PEG ratio of 1.36 and a beta of 2.35. The company's 50-day moving average is $19.57 and its 200-day moving average is $19.67. The company has a current ratio of 2.48, a quick ratio of 1.79 and a debt-to-equity ratio of 0.55. Core Laboratories Inc. has a 52-week low of $13.82 and a 52-week high of $25.13.

Core Laboratories (NYSE:CLB - Get Free Report) last posted its earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share for the quarter, topping analysts' consensus estimates of $0.21 by $0.04. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%. The company had revenue of $134.40 million during the quarter, compared to analyst estimates of $134.16 million. During the same quarter in the prior year, the business earned $0.22 earnings per share. Core Laboratories's revenue was up 7.2% on a year-over-year basis. On average, equities research analysts forecast that Core Laboratories Inc. will post 0.8 EPS for the current fiscal year.

Core Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, November 25th. Shareholders of record on Monday, November 4th were paid a $0.01 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $0.04 annualized dividend and a yield of 0.24%. Core Laboratories's dividend payout ratio (DPR) is presently 6.15%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.